Drive Wealth Management LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 28.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,933 shares of the healthcare conglomerate's stock after selling 1,154 shares during the period. Drive Wealth Management LLC's holdings in UnitedHealth Group were worth $1,715,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group during the 3rd quarter valued at $27,000. Macroview Investment Management LLC increased its stake in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock valued at $28,000 after buying an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $31,000. Global Wealth Strategies & Associates increased its position in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. Finally, Signature Resources Capital Management LLC raised its holdings in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 18 shares during the period. 87.86% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several research firms have weighed in on UNH. Cantor Fitzgerald increased their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the stock an "overweight" rating in a report on Wednesday, October 16th. TD Cowen lifted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a "buy" rating in a report on Friday, October 18th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Tuesday, November 12th. Bank of America dropped their price objective on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a research note on Wednesday, October 16th. Finally, Stephens cut their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating for the company in a report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average price target of $615.53.
View Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Stock Performance
UnitedHealth Group stock traded down $2.58 during mid-day trading on Monday, hitting $589.65. The company had a trading volume of 2,529,101 shares, compared to its average volume of 3,882,905. The company has a market capitalization of $542.64 billion, a price-to-earnings ratio of 38.29, a P/E/G ratio of 1.74 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company's fifty day moving average is $582.84 and its 200-day moving average is $549.98. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts' consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts' expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business's revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business earned $6.56 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.72%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.